Market Research Logo

Global Human Immunodeficiency Virus (HIV) Market: Industry Analysis & Outlook (2017-2021)

Global Human Immunodeficiency Virus (HIV) Market: Industry Analysis & Outlook (2017-2021)

HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.

HIV does not get spread easily into human. Only certain body fluids of an infected person can transmit HIV into others. HIV never gets transmitted through casual contacts like handshakes, sharing food or water. It has certain transmission ways including blood transmission of an infected person to non-infected person, exchange of body fluids like semen, pre-seminal or vaginal fluids during unprotected physical contacts and from a mother to child during pregnancy or breastfeeding.

HIV therapeutics market is likely to witness a growth with increasing demand for single tablet regimens and growth of HIV diagnostic market is expected to be driven by increasing technological advancements in diagnosis tests.

Middle East and Africa are the major contributors to the global HIV market supported by increased prevalence of HIV due to rising drug abuse and unprotected physical contacts among adolescents. Asia-Pacific is likely to experience further growth of HIV market due to recent development in HIV treatments.

The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures.

The report “Global HIV Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S along with the global market. The report profiles players of the market including Johnson & Johnson, Merck and Co., Gilead and GlaxoSmithKline Plc.


1. Overview
1.1 HIV
Table 1: Lifecycle of HIV
Table 2: Classes of Drugs with their Functions
2. Global HIV Market
2.1 Global HIV Therapeutics Market Forecast by Value
Table 3: Global HIV Therapeutics Market Forecast by Value (2016-2021)
2.2 Global HIV Therapeutics Market by Drug Class
Table 4: Global HIV Therapeutics Market by Drug Class (2016)
2.2.1 Global Integrase Inhibitor Market Forecast by Value
Table 5: Global Integrase Inhibitor Market Forecast by Value (2016-2021)
2.2.2 Global NNRTI Market Forecast by Value
Table 6: Global NNRTI Market Forecast by Value (2016-2021)
2.2.3 Global Protease Inhibitor Market Forecast by Value
Table 7: Global Protease Inhibitor Market Forecast by Value (2016-2021)
2.3 HIV Therapeutics Market by Brand
Table 8: Global HIV Therapeutics Market by Brand (2016)
2.4 HIV Diagnostic Market Forecast by Value
Table 9: Global HIV Diagnostic Market Forecast by Value (2016-2021)
2.5 HIV Diagnostic Market by Type
Table 10: Global HIV Diagnostic Market by Type (2016)
2.5.1 Global CD4 Tests Market Forecast by Value
Table 11: Global CD4 Tests Market Forecast by Value (2016-2021)
2.5.2 Global Viral Load Tests Market Forecast by Value
Table 12: Global Viral Load Tests Market Forecast by Value (2016-2021)
2.6 HIV Patient Population
Table 13: Global HIV Patient Population (2012-2016)
2.7 HIV Patient Population Forecast
Table 14: Global HIV Patient Population Forecast (2017-2021)
2.8 HIV Patient Population by Region
Table 15: Global HIV Patient Population by Region (2016)
2.9 New HIV Infected Population
Table 16: Global New HIV Infected Patient Population (2012-2016)
2.10 New HIV Infected Population Forecast
Table 17: Global New HIV Infected Patient Population Forecast (2017-2021)
2.11 New HIV Infected Population by Region
Table 18: Global New HIV Infected Patient Population by Region (2016)
2.12 HIV Patient Population on ART
Table 19: Global HIV Population on ART (2012-2016)
2.13 HIV Patient Population on ART Forecast
Table 20: Global HIV Population Forecast on ART (2017-2021)
2.14 HIV Patient Population on ART by Region
Table 21: Global HIV Population on ART by Region (2016)
3. Regional HIV Market
3.1 The U.S. HIV Patient Population Forecast
Table 22: The U.S. HIV Patient Population Forecast (2016-2021)
3.2 The U.S. Diagnosed HIV Population Forecast
Table 23: The U.S. Diagnosed HIV Population Forecast (2016-2021)
3.3 The U.S HIV Population on ART Forecast
Table 24: The U.S HIV Population on ART Forecast (2016-2021)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Decreasing HIV related Death Rates
Table 25: Global HIV Patients Death Rate (2012-2016)
4.1.2 Low Awareness of HIV Transmission
4.1.3 Government Initiative to Promote HIV Treatment
4.2 Key Trends
4.2.1 Progressing HIV Drugs Under Pipeline
Table 26: Pipeline Compounds of HIV Drugs (2016)
4.2.2 Increasing Adoption of STR
4.2.3 Development of Technologically Advanced Diagnostic Products
4.3 Challenges
4.3.1 Decreasing Global HIV Funds
Table 27: Global HIV Fund Allocated (2012-2016)
4.3.2 Social Stigma and Discrimination
4.3.3 Treatment Failures
5. Competition
5.1 Market Share by Company
Table 28: Global HIV Therapeutic Market Share by Company (2016)
5.2 Revenue Comparison
Table 29: Global HIV Therapeutics Market- Key Companies Revenue Comparison (2016)
6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Business Overview
Table 30: Johnson & Johnson Revenue by Product Segment (2016)
6.1.2 Financial Overview
Table 31: Johnson & Johnson Revenue and Net Earnings (2012-2016)
6.1.3 Business Strategies
Table 32: Johnson & Johnson Research and Development Expenditure (2014-2016)
6.2 Merck & Co.
6.2.1 Business Overview
Table 33: Merck & Co. Sales by Business Segment (2016)
6.2.2 Financial Overview
Table 34: Merck & Co. Sales and Net Income (2012-2016)
6.2.3 Business Strategies
Table 35: Merck & Co. R&D Expenditure (2014-2016)
6.3 Gilead
6.3.1 Business Overview
Table 36: Gilead Revenue by Segment (2016)
6.3.2 Financial Overview
Table 37: Gilead Total Revenue and Net Income (2012-2016)
6.3.3 Business Strategies
Table 38: Gilead R&D Expenditure (2014-2016)
6.4 GlaxoSmithKline Plc.
6.4.1 Business Overview
Table 39: GlaxoSmithKline Plc. Revenue by Segment (2016)
6.4.2 Financial Overview
Table 40: GlaxoSmithKline Plc. Revenue (2012-2016)
6.4.3 Business Strategies
Table 41: GlaxoSmithKline Plc. R&D Expenditure (2014-2016)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report